CAS 2166487-21-2

Formula: C31H39FN6O6S2

InChI: InChI=1S/C31H39FN6O6S2/c32-21-7-5-10-23(18-21)46(43,44)38-26(13-3-4-15-33-31(45)34-16-14-28(39)40)29(41)37-27(30(42)36-22-8-6-9-22)17-20-19-35-25-12-2-1-11-24(20)25/h1-2,5,7,10-12,18-19,22,26-27,35,38H,3-4,6,8-9,13-17H2,(H,36,42)(H,37,41)(H,39,40)(H2,33,34,45)/t26-,27-/m0/s1

InChI key: NEJMWPNVCQYZKG-SVBPBHIXSA-N

SMILES: C1CC(C1)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCCCNC(=S)NCCC(=O)O)NS(=O)(=O)C4=CC=CC(=C4)F

SIRT5 inhibitor 1

CAS: 2166487-21-2

SIRT5 inhibitor 1

Formula: C₃₁H₃₉FN₆O₆S₂

Purity: ≥95%

Molecular weight: 674.81

Ref: 54-BUP04637

SIRT5 inhibitor 1

CAS: 2166487-21-2

Formula: C₃₁H₃₉FN₆O₆S₂

Purity: 99%

Molecular weight: 674.8064

Ref: IN-DA01EO65

SIRT5 inhibitor 1

CAS: 2166487-21-2

3-(3-((S)-6-(((S)-1-(Cyclobutylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-5-((3-fluorophenyl)sulfonamido)-6-oxohexyl)thioureido)propanoic acid

Formula: C₃₁H₃₉FN₆O₆S₂

Purity: 99%

Molecular weight: 674.81

Ref: IN-DG01118355

Sirt5 inhibitor 1

CAS: 2166487-21-2

Sirt5 inhibitor 1 is a chemical that reacts with the lysine residues in proteins. It has been shown to inhibit prognosis in patients with cancer or other degenerative diseases. Sirt5 inhibitor 1 has also been shown to promote hematopoiesis and increase the ATP levels in human erythrocytes. It may also be used as a potential drug to treat mitochondrial superoxide-induced toxicity, which occurs during periods of oxidative stress.

Formula: C₃₁H₃₉FN₆O₆S₂

Purity: Min. 95%

Molecular weight: 674.8 g/mol

Ref: 3D-RLD48721

SIRT5 inhibitor 1

CAS: 2166487-21-2

SIRT5 inhibitor 1 targets human Sirtuin 5 deacylase, with an IC50 of 0.11 μM, linked to aging diseases.

Formula: C₃₁H₃₉FN₆O₆S₂

Purity: 97.8%

Color and Shape: White Solid

Molecular weight: 674.806

Ref: TM-T12921